Guanglei Yu

527 total citations · 1 hit paper
31 papers, 314 citations indexed

About

Guanglei Yu is a scholar working on Urology, Rehabilitation and Epidemiology. According to data from OpenAlex, Guanglei Yu has authored 31 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Urology, 8 papers in Rehabilitation and 7 papers in Epidemiology. Recurrent topics in Guanglei Yu's work include Hair Growth and Disorders (17 papers), Wound Healing and Treatments (8 papers) and Autoimmune Bullous Skin Diseases (5 papers). Guanglei Yu is often cited by papers focused on Hair Growth and Disorders (17 papers), Wound Healing and Treatments (8 papers) and Autoimmune Bullous Skin Diseases (5 papers). Guanglei Yu collaborates with scholars based in United States, Japan and Spain. Guanglei Yu's co-authors include Yves Dutronc, Margaret Gamalo, Brett King, Jill Shwed McCollam, Manabu Ohyama, Justin Ko, Katrin Holzwarth, Maryanne M. Senna, Natasha Atanaskova Mesinkovska and Emily Edson‐Heredia and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Gastroenterology and Journal of Investigative Dermatology.

In The Last Decade

Guanglei Yu

27 papers receiving 310 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)

2023 65 citations Ohsang Kwon, Maryanne M. Senna et al. American Journal of Clinical Dermatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guanglei Yu United States	8	185	134	80	50	45	31	314
Virginia C. Weiss United States	7	88 0.5×	104 0.8×	37 0.5×		56 1.2×	10	238
Atsuko Fukuyasu Japan	10	19 0.1×	190 1.4×	68 0.8×		20 0.4×	32	309
Yifan Hu China	10	6 0.0×	71 0.5×	23 0.3×		67 1.5×	23	268
Sylvia Lew Israel	8	21 0.1×	17 0.1×	54 0.7×	1 0.0×	43 1.0×	17	237
Edmund Lee United States	6	2 0.0×	43 0.3×	13 0.2×	9 0.2×	22 0.5×	6	251
Igor Bartenjev Slovenia	9	5 0.0×	63 0.5×	6 0.1×		35 0.8×	18	178
Anupama Singh United States	10	9 0.0×	35 0.3×	5 0.1×		92 2.0×	21	210
Stefan Woehrl Switzerland	2	3 0.0×	77 0.6×	17 0.2×		49 1.1×	2	230
Sophie Roenneberg Germany	6	2 0.0×	115 0.9×	80 1.0×		20 0.4×	9	243
Kristina Callis-Duffin United States	9	2 0.0×	110 0.8×	22 0.3×		72 1.6×	13	418

Countries citing papers authored by Guanglei Yu

Since Specialization

Citations

This map shows the geographic impact of Guanglei Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guanglei Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guanglei Yu more than expected).

Fields of papers citing papers by Guanglei Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guanglei Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guanglei Yu. The network helps show where Guanglei Yu may publish in the future.

Co-authorship network of co-authors of Guanglei Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Guanglei Yu. A scholar is included among the top collaborators of Guanglei Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guanglei Yu. Guanglei Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Scott D., Séverine Vermeire, Ryan C. Ungaro, et al.. (2025). Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 Study. The American Journal of Gastroenterology. 120(8). 1809–1819.

Mostaghimi, Arash, Brittany G. Craiglow, Brett King, et al.. (2025). Understanding eyebrow and eyelash involvement in patients with alopecia areata and responsiveness to treatment with baricitinib. British Journal of Dermatology. 193(2). 240–249. 1 indexed citations

Ko, Justin, Ohsang Kwon, Sergio Vañó‐Galván, et al.. (2024). Baricitinib Withdrawal and Retreatment in Patients With Severe Alopecia Areata. JAMA Dermatology. 160(10). 1075–1075. 14 indexed citations

Zlotogorski, Abraham, Sergio Vañó‐Galván, Bianca Maria Piraccini, et al.. (2024). Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials. SHILAP Revista de lepidopterología. 3(5). 1564–1569.

Senna, Maryanne M., Arash Mostaghimi, Manabu Ohyama, et al.. (2024). Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2. Journal of the European Academy of Dermatology and Venereology. 38(3). 583–593. 21 indexed citations

King, Brett, Manabu Ohyama, Maryanne M. Senna, et al.. (2024). Outcomes of down-titration in patients with severe scalp alopecia areata initially treated with baricitinib 4-mg: Week 152 data from BRAVE-AA2. Journal of the American Academy of Dermatology. 92(2). 299–306. 4 indexed citations

Senna, Maryanne M., Arash Mostaghimi, Manabu Ohyama, et al.. (2024). 49690 Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2. Journal of the American Academy of Dermatology. 91(3). AB251–AB251. 1 indexed citations

Mostaghimi, Arash, Antonellá Tosti, Amy McMichael, et al.. (2024). Concordance between clinician-reported and patient-reported outcomes of eyebrow and eyelash hair loss in patients with severe alopecia areata: Results from BRAVE-AA1 and BRAVE-AA2 studies. Journal of the American Academy of Dermatology. 91(4). 729–732. 1 indexed citations

Zhang, Xiaoman, et al.. (2024). TKMBR: Temporal Knowledge Graph-based Multi-Behavior Recommendation. 1–8. 2 indexed citations

10.

Ko, Justin, Wilma F. Bergfeld, Yves Dutronc, et al.. (2023). Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata. JAMA Dermatology. 159(9). 970–970. 9 indexed citations

11.

Shapiro, Jerry, Justin Ko, Alexander Egeberg, et al.. (2023). 41247 Baseline distribution of eyebrow and eyelash loss by severity of scalp hair loss in phase 3 trials of baricitinib for alopecia areata. Journal of the American Academy of Dermatology. 89(3). AB127–AB127. 1 indexed citations

12.

Kwon, Ohsang, Maryanne M. Senna, Rodney Sinclair, et al.. (2023). Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2). American Journal of Clinical Dermatology. 24(3). 443–451. 65 indexed citations breakdown →

13.

King, Brett, Manabu Ohyama, Maryanne M. Senna, et al.. (2023). 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2. Journal of the American Academy of Dermatology. 89(3). AB69–AB69. 1 indexed citations

14.

Zhang, Linlin, et al.. (2023). Predicting disease genes based on multi-head attention fusion. BMC Bioinformatics. 24(1). 6 indexed citations

15.

Egeberg, Alexander, et al.. (2023). Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review. Dermatology and Therapy. 13(12). 2951–2991. 12 indexed citations

16.

King, Brett, Justin Ko, Seth Forman, et al.. (2021). Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study. Journal of the American Academy of Dermatology. 85(4). 847–853. 90 indexed citations

17.

Dong, Gaohong, Lu Mao, Bo Huang, et al.. (2020). The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring. Journal of Biopharmaceutical Statistics. 30(5). 882–899. 43 indexed citations

18.

Yu, Guanglei, Yang Li, Liang Zhu, et al.. (2018). An additive–multiplicative mean model for panel count data with dependent observation and dropout processes. Scandinavian Journal of Statistics. 46(2). 414–431. 6 indexed citations

19.

Yu, Guanglei, Liang Zhu, Yang Li, Jianguo Sun, & Leslie L. Robison. (2017). Regression analysis of mixed panel count data with dependent terminal events. Statistics in Medicine. 36(10). 1669–1680. 4 indexed citations

20.

Yu, Guanglei, Hui Zou, Russell L. Prewitt, & Michael A. Hill. (1999). Impaired Arteriolar Mechanotransduction in Experimental Diabetes Mellitus. Journal of Diabetes and its Complications. 13(5-6). 235–242. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact